Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.

NCT02085824 is registered in ClinicalTrials.gov with Centre of Postgraduate Medical Education as lead sponsor.

NCT NCT02085824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02085824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.
Lead sponsor
Centre of Postgraduate Medical Education
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2012
Completion date
April 30, 2014
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss, hip osteoarthritis